Beta‐sheet breaker strategy for the treatment of Alzheimer's disease
- 1 June 2002
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 56 (2) , 184-193
- https://doi.org/10.1002/ddr.10074
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- FAD Mutations in Presenilin-1 or Amyloid Precursor Protein Decrease the Efficacy of a γ-Secretase Inhibitor: Evidence for Direct Involvement of PS1 in the γ-Secretase Cleavage ComplexNeurobiology of Disease, 2000
- Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer’s disease 1 1Edited by P. E. WrightJournal of Molecular Biology, 1999
- ALZHEIMER'S DISEASE: Genetic Studies and Transgenic ModelsAnnual Review of Genetics, 1998
- Structural and kinetic features of amyloid β-protein fibrillogenesisAmyloid, 1998
- Passage of peptides across the blood-brain barrier: Pathophysiological perspectivesLife Sciences, 1996
- Mechanisms of Neuronal Degeneration in Alzheimer's DiseaseNeuron, 1996
- Three-Dimensional Structures of the Amyloid β Peptide (25−35) in Membrane-Mimicking EnvironmentBiochemistry, 1996
- Prolines and Aamyloidogenicity in Fragments of the Alzheimer's Peptide .beta./A4Biochemistry, 1995
- Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch‐type hereditary cerebral haemorrhage with amyloidosisEuropean Journal of Biochemistry, 1994
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992